Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: DeCode launches genetic trial

By admin

Created May 17 2006 - 7:01pm

Iceland's DeCode Genetics has launched a closely watched Phase III trial of DG031 to prevent heart attacks. The company will track the results of 3,400 African-American subjects who have a genetic variant linked to heart attacks. Report [1]

Decode Genetics
heart disease
Phase III

Source URL: http://www.fiercebiotech.com/story/spotlight-decode-launches-genetic-trial/2006-05-18

Links:
[1] http://www.businessweek.com/ap/financialnews/D8HLP6G00.htm?campaign_id=apn_home_down&chan=db